Security Benefit Life Insurance Company’s Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 HLGN.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding HLGN.WS
Security Benefit Life Insurance Company's HLGN.WS Position: Q1 2024 in Review
Security Benefit Life Insurance Company sold out of Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (HLGN.WS) in Q1 2024, closing a stake of 326,520 shares — an estimated $3.82K sold.
Security Benefit Life Insurance Company first reported a position in HLGN.WS in Q4 2021 and held it in 8 quarters. The position peaked at $555K in Q4 2021. 1 fund tracked by Wall St. Rank holds HLGN.WS as of Q1 2024.
- Security Benefit Life Insurance Company reported no remaining Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position as of Q1 2024 after selling out during the quarter.
- Security Benefit Life Insurance Company sold 326,520 Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 shares in Q1 2024, an estimated $3.82K.
- Security Benefit Life Insurance Company first reported a position in Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 in Q4 2021 and held it in 8 quarters.
- Security Benefit Life Insurance Company's Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position peaked at $555K in Q4 2021.
- 1 fund tracked by Wall St. Rank held Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 as of Q1 2024.
Based on Security Benefit Life Insurance Company's 13F filing for Q1 2024, filed 7 May 2024.